Alexandria Real Estate Equities
ARE
#2076
Rank
C$13.65 B
Marketcap
C$78.38
Share price
3.62%
Change (1 day)
-20.48%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -C$0.84 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are C$2.85 Billion. In 2025 the company made an earning of -C$1.41 Billion a decrease over its 2024 earnings that were of C$0.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.84 Billion-40.37%
2025 -C$1.41 Billion-242.13%
2024 C$0.98 B96.11%
2023 C$0.50 B-53.56%
2022 C$1.08 B-3.96%
2021 C$1.13 B-20.26%
2020 C$1.41 B72.88%
2019 C$0.82 B3.11%
2018 C$0.79 B73.54%
2017 C$0.45 B464.88%
2016 C$81.12 M-77.32%
2015 C$0.35 B36.31%
2014 C$0.26 B-10.81%
2013 C$0.29 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$15.03 B-1,817.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.17 B-5,147.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.89 B-1,573.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.90 B-1,688.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$1.64 B-288.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.62 B-1,656.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.23 B-241.04%๐Ÿ‡บ๐Ÿ‡ธ USA